Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers
Public ClinicalTrials.gov record NCT06182358. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized Controlled Trial to Evaluate the Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers
Study identification
- NCT ID
- NCT06182358
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Tarsus Pharmaceuticals, Inc.
- Industry
- Enrollment
- 145 participants
Conditions and interventions
Conditions
Interventions
- Lotilaner ophthalmic solution, 0.25% Drug
- Vehicle control Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 26, 2023
- Primary completion
- Jan 26, 2025
- Completion
- Jan 26, 2025
- Last update posted
- Jul 1, 2025
2023 – 2025
United States locations
- U.S. sites
- 14
- U.S. states
- 14
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site | Cave Creek | Arizona | 85331 | — |
| Site | Long Beach | California | 90805 | — |
| Vision Institute | Colorado Springs | Colorado | 80907 | — |
| Site | Delray Beach | Florida | 33484 | — |
| Site | Indianapolis | Indiana | 46240 | — |
| Site | Pittsburg | Kansas | 66762 | — |
| Site | Louisville | Kentucky | 40206 | — |
| Site | Edina | Minnesota | 55436 | — |
| Site | Shelby | North Carolina | 28150 | — |
| Site | Fargo | North Dakota | 58103 | — |
| Site | Powell | Ohio | 43065 | — |
| Site | Cranberry Township | Pennsylvania | 16066 | — |
| Site | Memphis | Tennessee | 38104 | — |
| Site | Houston | Texas | 77005 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06182358, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 1, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06182358 live on ClinicalTrials.gov.